Patients who undergo surgery of catheter insertion or inguinal hernia
Conditions
Interventions
An applicator of 1.5% Olamexidine gluconate is used at surgical site. The skin site exposed to 1.5% Olamexidine gluconate are inspected daily by the bed side nursse or physician to assess any adverse
Sponsors
National Center for Child Health and Development
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: (1)Children who undergo surgery for catheter insertion or inguinal hernia from 1 to 16 years of age. (2)No abnormal appearance of the skin for surgical incision. (3)Informed concent was obtained from guardians.
Exclusion criteria
Exclusion criteria: (1)History of drug sensitivity. (2)History of shock or hypersensitivity against Chlorhexidine gluconate. (3)Patients having cutaneous disease (4)Any patients who was judged as inappropriate candidate to enroll this study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Primary outcome was determined to assess the rate of any adverse effect such as labo data, vital sign, subjective and objective symptom, erythema or irritation of the skin. | — |
Countries
Japan
Contacts
Public ContactKyoko Hagino
National Center for Child Health and Development Division of Medical Research
Outcome results
None listed